Philip Tsai
Chief Technical Officer, Immunome Inc.
Bought, 12 months
$0.2M
Sold, 12 months
$0.0M
Companies
1
Latest trade
Dec 19, 2025
Companies
Immunome Inc.Chief Technical Officer +$0.2M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.